Cancer BiologybioRxiv
Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice
D. H. Shin, H. Jiang, A. G. Gillard…·J. Fueyo
This paper develops a chimeric oncolytic adenovirus that evades neutralizing antibodies and shows improved anti-glioma efficacy in mice.